Prevention Science and Methodology Group (PMSG) Virtual Grand Rounds: Cost-Effectiveness of Care Models to Support HCV and HIV Elimination in People Who Inject Drugs

by Sarah Gutkind, MSPH

November 12, 2019

Recent Posts

Cost-effectiveness of Extended-release Injectable Naltrexone among Incarcerated Persons with Opioid Use Disorder Before Release from Prison Versus After Release
August 01, 2022

Intern Spotlight: Grace L. Edwards, Jessica Girard, Lyric Harris, and Antara Saha
July 25, 2022

Five Researchers Receive CHERISH Pilot Awards to Advance the Treatment of Substance Use Disorders, HCV, and HIV
July 17, 2022

Evidence for Supportive Prenatal Substance Use Policies
June 29, 2022

CHERISH Returns to Conferences in Person
May 09, 2022